Alert! This Pot Retail Stock Is a Bargain

Alcanna Inc. (TSX:CLIQ) stock has sunk close to a 52-week low in the late summer, but it still offers solid value as it expands its cannabis retail footprint.

Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

The roll-out of cannabis retail can only be called a disappointment as we approach the one-year anniversary of recreational legalization. Ontario, Canada’s most populous province, adopted a private retail model after the election of the Ford-led Progressive Conservative government in the summer of 2018.

At the time, this appeared to be very encouraging, but Ontario’s cannabis retail roll-out has been sluggish on the brick-and-mortar side. Its e-commerce offering, the Ontario Cannabis Store (OCS), was marred by technical issues early on. Licences have been handed out sparingly to over-the-counter retailers in part due to supply shortages. Fortunately, this problem will dissipate as we move into the next decade.

One expanding pot retailer to watch

Alcanna (TSX:CLIQ) is an Edmonton-based company that has historically been in the liquor retail business. It announced that it would jump into cannabis retail ahead of recreational legalization, and its on-the-ground results have been promising. The stock, however, has encountered volatility. Shares have dropped 11.5% over the past three months as of close on September 3.

The company released its second-quarter 2019 results on August 9. Alcanna reported 20.9% sales growth in the quarter compared to the prior year and same-store sales growth of 8.2% in its core Canadian liquor retail business. Naturally, its cannabis retail unit drew considerable attention.

It opened a Nova Cannabis retail outlet on Queen Street West in Toronto back in April. Sales have averaged a healthy $450,000 per week, making it the highest-volume store of all its over 250 locations. This illustrates just how explosive cannabis retail can be for Alcanna going forward. In May, Alcanna opened three additional Nova Cannabis stores in Alberta, bringing the total to the province to eight.

Alcanna aims to have 15-20 retail cannabis locations by the end of 2019. The growth rate at its cannabis locations has been very encouraging, and the slated expansion should fuel Alcanna’s earnings into the next decade.

For the first six months of 2019 Alcanna has reported sales of $350 million compared to $294 million in the previous year, and the operating profit has climbed to $8.7 million compared to a marginal loss in H1 2018. Sales growth has been powered by new acquisitions and the opening of said cannabis retail locations.

Why Alcanna looks discounted right now

Shares of Alcanna possess a solid price-to-book ratio of 2.1, but it still has a lot of ground to make up in terms of profitability in order to post a favourable price-to-earnings ratio. The stock had an RSI of 30 as of close on September 3. This puts Alcanna just outside technically oversold territory.

Alcanna terminated its quarterly cash dividend back in December 2018, so this is a target for growth-oriented investors. On that front, I like the stock’s value as we open the month of September. Its foray into cannabis retail has been a success, and the opening of new stores should continue to fuel same-store sales growth while its liquor business has also made encouraging strides.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »